Fan Zhang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Fan Zhang has a total of 39 co-authors. Here are the top co-authors by number of shared publications:
- Michael P. Whyte
Division of Bone and Mineral Diseases, Department of Internal Medicine, Washington University School of Medicine, St Louis, MO 63110, USA; Center for Metabolic Bone Disease and Molecular Research, Shriners Hospitals for Children-St. Louis, St. Louis, MO 63110, USA
8 shared publications - Deborah Wenkert
Center for Metabolic Bone Disease and Molecular Research, Shriners Hospitals for Children - St. Louis, St. Louis, MO 63110, USA
6 shared publications - Gary S. Gottesman
Center for Metabolic Bone Disease and Molecular Research, Shriners Hospitals for Children-St. Louis, St. Louis, MO 63110, USA
4 shared publications - Steven Mumm
Center For Metabolic Bone Disease and Molecular Research, Shriners Hospitals for Children - St. Louis, St. Louis, MO 63110, USA; Division of Bone and Mineral Diseases, Department of Internal Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA
4 shared publications - Margaret Huskey
Division of Bone and Mineral Diseases, Department of Internal Medicine, Washington University School of Medicine at Barnes-Jewish Hospital, St. Louis, MO 63110, USA
3 shared publications - Vinieth Ms Bijanki
Center for Metabolic Bone Disease and Molecular Research, Shriners Hospitals for Children - St. Louis, St. Louis, MO 63110, USA
3 shared publications
Latest Publications
- Open Access
- 7 January 2020
- Published by Oxford University Press (OUP) in Journal of Bone and Mineral Research
- Vol. 35 (5) , 920-931
X-Linked Hypophosphatemia: Uniquely Mild Disease Associated With PHEX 3′-UTR Mutation c.*231A>G (A Retrospective Case–Control Study)
X‐linked hypophosphatemia (XLH), the most prevalent heritable renal phosphate (Pi) wasting disorder, is caused by deactivating mutations of PHEX. Consequently, circulating phosphatonin FGF23 becomes elevated and hypophosphatemia in affected children leads to rickets with skeletal deformity and reduced linear growth while affected adults suffer from osteomalacia and forms of ectopic mineralization. In 2015, we reported uniquely mild XLH in six children and four of their mothers carrying the non‐coding PHEX 3′‐UTR mutation c.*231A>G. Herein, we characterize this mild XLH variant by comparing its features in 30 individuals to 30 age‐ and sex‐matched patients with XLH but without the 3′‐UTR mutation. The “UTR” and “XLH” groups, both comprising 17 children (2‐17 years, 3 girls) and 13 adults (23‐63 years, 10 women), had mean ages of 23 years. Only 43% of the UTR group versus 90% of the XLH group had received medical treatment for their disorder, including 0% versus 85% of the females, respectively (ps< 0.0001). The UTR group was taller: mean (SD) height Z‐score (HZ) ‐1.0 (1.0) versus ‐2.0 (1.4) (p=0.0034), with significantly greater height for females [‐0.9 (0.7) versus ‐2.3 (1.4), (p=0.0050)] but not males [‐1.2 (1.1) versus ‐1.9 (1.5) (p=0.1541)], respectively. Mean (SD) “arm span Z‐score” (AZ) did not differ between the UTR ‐0.8 (1.3) versus XLH ‐1.3 (1.8) groups (p=0.2269). Consequently, the UTR group was more proportionate with a mean ∆Z (AZ – HZ) of 0.1 (0.6) versus 0.7 (1.0) (p=0.0158), respectively. Compared to the XLH group, the UTR group had significantly higher fasting serum Pi and TmP/GFR (ps≤0.0060), serum FGF23 concentrations within the reference range (p=0.0068), and similar serum alkaline phosphatase levels (p = 0.6513). UTR lumbar spine bone mineral density Z‐score was higher (p=0.0343). Thus, the 3′‐UTR variant of XLH is distinctly mild, especially in girls and women, posing challenges for its recognition and management.
- 7 January 2020
- Published by Oxford University Press (OUP) in Journal of Bone and Mineral Research
- Vol. 35 (5) , 920-931
Open AccessX-Linked Hypophosphatemia: Uniquely Mild Disease Associated With PHEX 3′-UTR Mutation c.*231A>G (A Retrospective Case–Control Study)
X‐linked hypophosphatemia (XLH), the most prevalent heritable renal phosphate (Pi) wasting disorder, is caused by deactivating mutations of PHEX. Consequently, circulating phosphatonin FGF23 becomes elevated and hypophosphatemia in affected children leads to rickets with skeletal deformity and reduced linear growth while affected adults suffer from osteomalacia and forms of ectopic mineralization. In 2015, we reported uniquely mild XLH in six children and four of their mothers carrying the non‐coding PHEX 3′‐UTR mutation c.*231A>G. Herein, we characterize this mild XLH variant by comparing its features in 30 individuals to 30 age‐ and sex‐matched patients with XLH but without the 3′‐UTR mutation. The “UTR” and “XLH” groups, both comprising 17 children (2‐17 years, 3 girls) and 13 adults (23‐63 years, 10 women), had mean ages of 23 years. Only 43% of the UTR group versus 90% of the XLH group had received medical treatment for their disorder, including 0% versus 85% of the females, respectively (ps< 0.0001). The UTR group was taller: mean (SD) height Z‐score (HZ) ‐1.0 (1.0) versus ‐2.0 (1.4) (p=0.0034), with significantly greater height for females [‐0.9 (0.7) versus ‐2.3 (1.4), (p=0.0050)] but not males [‐1.2 (1.1) versus ‐1.9 (1.5) (p=0.1541)], respectively. Mean (SD) “arm span Z‐score” (AZ) did not differ between the UTR ‐0.8 (1.3) versus XLH ‐1.3 (1.8) groups (p=0.2269). Consequently, the UTR group was more proportionate with a mean ∆Z (AZ – HZ) of 0.1 (0.6) versus 0.7 (1.0) (p=0.0158), respectively. Compared to the XLH group, the UTR group had significantly higher fasting serum Pi and TmP/GFR (ps≤0.0060), serum FGF23 concentrations within the reference range (p=0.0068), and similar serum alkaline phosphatase levels (p = 0.6513). UTR lumbar spine bone mineral density Z‐score was higher (p=0.0343). Thus, the 3′‐UTR variant of XLH is distinctly mild, especially in girls and women, posing challenges for its recognition and management.
- 1 October 2015
- Published by Elsevier in Molecular Immunology
- Vol. 67 (2) , 584-595
Role of complement receptor 1 (CR1; CD35) on epithelial cells: A model for understanding complement-mediated damage in the kidney
- 1 October 2015
- Published by Elsevier in Molecular Immunology
- Vol. 67 (2) , 584-595
Role of complement receptor 1 (CR1; CD35) on epithelial cells: A model for understanding complement-mediated damage in the kidney
- Top Cited Papers
Hypophosphatasia: Validation and expansion of the clinical nosology for children from 25years experience with 173 pediatric patients